DekaBank Deutsche Girozentrale’s 89bio ETNB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-90,000	Closed	-$1.11M	–	1184
2025 Q4	$1.11M	Hold	90,000	–	–	﹤0.01%	861
2025 Q3	$1.09M	Hold	90,000	–	–	﹤0.01%	855
2025 Q2	$1.1M	Hold	90,000	–	–	﹤0.01%	845
2025 Q1	$1.02M	Hold	90,000	–	–	﹤0.01%	841
2024 Q4	$965K	Hold	90,000	–	–	﹤0.01%	879
2024 Q3	$1.02M	Hold	90,000	–	–	﹤0.01%	882
2024 Q2	$1.02M	Hold	90,000	–	–	﹤0.01%	875
2024 Q1	$1.02M	Hold	90,000	–	–	﹤0.01%	871
2023 Q4	$1.02M	Buy	90,000 +70,000	+350%	+$643K	﹤0.01%	896
2023 Q3	$309K	Hold	20,000	–	–	﹤0.01%	1121
2023 Q2	$354K	Hold	20,000	–	–	﹤0.01%	1090
2023 Q1	$298K	Buy	+20,000	New	+$261K	﹤0.01%	1129

DekaBank Deutsche Girozentrale's ETNB Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of 89bio (ETNB) in Q1 2026, closing a stake of 90,000 shares — an estimated $1.11M sold.

DekaBank Deutsche Girozentrale first reported a position in ETNB in Q1 2023 and held it in 12 quarters. The position peaked at $1.11M in Q4 2025. 0 funds tracked by Wall St. Rank hold ETNB as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining 89bio position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 90,000 89bio shares in Q1 2026, an estimated $1.11M.
DekaBank Deutsche Girozentrale first reported a position in 89bio in Q1 2023 and held it in 12 quarters.
DekaBank Deutsche Girozentrale's 89bio position peaked at $1.11M in Q4 2025.
0 funds tracked by Wall St. Rank held 89bio as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.